Report #2831286

Received Mar 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 16 yrs
State: MN
Recovered: Not recovered
Vaccinated: Dec 26, 2024
Onset: Jan 7, 2025
Days to onset: 12
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
COVID19	COVID19 (COVID19 (MODERNA))	MODERNA	UNK	8080748	IM

Symptoms (1)

Type 1 diabetes mellitus

Symptom narrative

Trigger type 1 diabetes; This spontaneous case was reported by a non-health professional and describes the occurrence of TYPE 1 DIABETES MELLITUS (Trigger type 1 diabetes) in a 16-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 8080748) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Dec-2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 50 microgram. On 07-Jan-2025, after starting mRNA-1273.712 (SPIKEVAX 2024-2025 PFS), the patient experienced TYPE 1 DIABETES MELLITUS (Trigger type 1 diabetes) (seriousness criterion medically significant). At the time of the report, TYPE 1 DIABETES MELLITUS (Trigger type 1 diabetes) had not resolved. The action taken with mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) was unknown. For mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use), the reporter did not provide any causality assessments. No Concomitant medications provided by the reporter. No treatment medications provided by the reporter.; Reporter's Comments: Company comment: The benefit-risk relationship of product is not affected by this report.